Joseph P. Dougherty
Chief Executive Officer at Seaview Securities LLC
Profile
Joseph P.
Dougherty founded Seaview Securities LLC in 2002 and currently serves as Co-Managing Director.
Previously, he was a Senior Biotechnology Research Analyst at Lehman Brothers, Inc. Dr. Dougherty was Chairman of the Strategic Initiatives Committee and a Director for AnorMED, Inc. until November 2006.
He worked with Warburg Dillon Read LLC (now UBS) from 1997 to 2000.
Dr. Dougherty was a Research Scientist at Gilead Sciences, Inc. from 1992 to 1997.
He worked on the synthesis of modified nucleic acids, methodologies for DNA-based diagnostics, and nucleic acid-targeted drugs at the Genetics Institute, Inc. from 1983 to 1987.
Dr. Dougherty has over 25 years of experience in science, biotechnology companies, and finance.
Dr. Dougherty received his AB degree in Chemistry from Harvard University (Laboratory of William von Eggers Doering) and a PhD in Bioorganic Chemistry from Columbia University (Laboratory of Ronald Breslow).
Joseph P. Dougherty active positions
| Companies | Position | Start |
|---|---|---|
Seaview Securities LLC
 Seaview Securities LLC Investment Banks/BrokersFinance Seaview Securities LLC provides investment banking services focused on the life sciences industry. The firm's services include private placements, mergers & acquisitions, financial and business strategy advisory, and underwriting services. The company was founded in January 2002 by Russell L. Pollack and Joseph P. Dougherty and is headquartered in New York, NY. | Chief Executive Officer | 01/01/2002 |
Former positions of Joseph P. Dougherty
| Companies | Position | End |
|---|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1987 |
| Warburg Dillon Read LLC | Analyst-Equity | - |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Analyst-Equity | 27/08/2002 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Director/Board Member | - |
Training of Joseph P. Dougherty
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Seaview Securities LLC
Seaview Securities LLC Investment Banks/BrokersFinance Seaview Securities LLC provides investment banking services focused on the life sciences industry. The firm's services include private placements, mergers & acquisitions, financial and business strategy advisory, and underwriting services. The company was founded in January 2002 by Russell L. Pollack and Joseph P. Dougherty and is headquartered in New York, NY. | Finance |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
| Warburg Dillon Read LLC | Finance |
- Stock Market
- Insiders
- Joseph P. Dougherty
